In vivo engineering of a human vasculature for bone tissue engineering applications

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3380-3386

  Steffens, Lilian ^a   Wenger, Andreas ^a   Stark, G Björn ^a   Finkenzeller, Günter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenesis; Bone tissue engineering; Chick chorioallantoic membrane; Endothelial cell; Osteoblast; SCID mouse; Spheroid; Vascularization

Indexed keywords

ANIMAL; ARTICLE; BONE; CATTLE; CELL CULTURE; CHICK EMBRYO; COCULTURE; CYTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MICROCIRCULATION; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); OSTEOBLAST; PATHOLOGY; PHASE CONTRAST MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; CATTLE; CELLS, CULTURED; CHICK EMBRYO; COCULTURE TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MICROCIRCULATION; MICROSCOPY, PHASE-CONTRAST; NEOVASCULARIZATION, PATHOLOGIC; OSTEOBLASTS; TISSUE ENGINEERING;

BOVINAE; MURINAE; MUS;

EID: 72649087696     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00418.x     Document Type: Article

References (31)

1. Griffith CK, Miller C, Sainson RC. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng. 2005, 11:257-66.
2. Young DM, Greulich KM, Weier HG. Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. J Burn Care Rehabil. 1996, 17:305-10.
3. Kneser U, Kaufmann PM, Fiegel HC. Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J Biomed Mater Res. 1999, 47:494-503.
4. Baumgartner I, Pieczek A, Manor O. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998, 97:1114-23.
5. Schumacher B, Pecher P, von Specht BU. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation. 1998, 97:645-50.
6. Kipshidze N, Chekanov V, Chawla P. Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. Tex Heart Inst J. 2000, 27:196-200.
7. Henry TD, Rocha-Singh K, Isner JM. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J. 2001, 142:872-80.
8. Fukuda S, Yoshii S, Kaga S. Angiogenic strategy for human ischemic heart disease: brief overview. Mol Cell Biochem. 2004, 264:143-9.
9. Schechner JS, Nath AK, Zheng L. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci USA. 2000, 97:9191-6.
10. Koike N, Fukumura D, Gralla O. Tissue engineering: creation of long-lasting blood vessels. Nature. 2004, 428:138-9.
11. Street J, Bao M, deGuzman L. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. 2002, 99:9656-61.
12. Wenger A, Stahl A, Weber H. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng. 2004, 10:1536-47.
13. Korff T, Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol. 1998, 143:1341-52.
14. Borges J, Tegtmeier FT, Padron NT. Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng. 2003, 9:441-50.
15. Pieper JS, Hafmans T, van Wachem PB. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res. 2002, 62:185-94.
16. Perets A, Baruch Y, Weisbuch F. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A. 2003, 65:489-97.
17. Zisch AH, Lutolf MP, Hubbell JA. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol. 2003, 12:295-310.
18. Rebar EJ, Huang Y, Hickey R. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med. 2002, 8:1427-32.
19. Bouis D, Boelens MC, Peters E. Combination of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) to improve angiogenic gene therapy. Angiogenesis. 2003, 6:185-92.
20. Korff T, Augustin HG. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci. 1999, 112:3249-58.
21. Haspel HC, Scicli GM, McMahon G. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvasc Res. 2002, 63:304-15.
22. Alajati A, Laib AM, Weber H. Spheroid-based engineering of a human vasculature in mice. Nat Methods. 2008, 5:439-45.
23. Orban JM, Marra KG, Hollinger JO. Composition options for tissue-engineered bone. Tissue Eng. 2002, 8:529-39.
24. Darland DC, D'Amore PA. TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis. 2001, 4:11-20.
25. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003, 9:653-60.
26. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003, 9:685-93.
27. Levenberg S, Rouwkema J, Macdonald M. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005, 23:879-84.
28. Rouwkema J, de Boer J, Van Blitterswijk CA. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng. 2006, 12:2685-93.
29. Gambini A, Mastantuono M, Di Giorgio L. Rehabitation of allograft with bone dehydrated with solvents in reconstruction after removal of bone tumors: MRI evaluation. Chir Organi Mov. 1999, 84:359-68.
30. Trentz OA, Hoerstrup SP, Sun LK. Osteoblasts response to allogenic and xenogenic solvent dehydrated cancellous bone in vitro. Biomaterials. 2003, 4:3417-26.
31. Kneser U, Stangenberg L, Ohnolz J. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med. 2006, 10:695-707.